Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

119.17
-1.2400-1.03%
Pre-market: 120.501.33+1.12%08:06 EST
Volume:540.65K
Turnover:64.94M
Market Cap:6.92B
PE:-36.31
High:122.48
Open:121.26
Low:118.77
Close:120.41
52wk High:130.23
52wk Low:73.16
Shares:58.08M
Float Shares:55.40M
Volume Ratio:0.48
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2819
EPS(LYR):-3.2819
ROE:-26.38%
ROA:-5.80%
PB:10.55
PE(LYR):-36.31

Loading ...

Stock Track | Glaukos Soars 14% After Hours on Strong Q3 Results and Upbeat Future Guidance

Stock Track
·
Oct 30, 2025

Glaukos Q3 Sales USD 133.5 Million Vs. IBES Estimate USD 122.5 Million

Reuters
·
Oct 30, 2025

Glaukos Corporation Reports Third Quarter Net Loss of $16.2 Million

Reuters
·
Oct 30, 2025

Glaukos Projects 2026 Net Sales of $600 Million to $620 Million

Reuters
·
Oct 30, 2025

Glaukos Corp: Preliminary 2026 Net Sales Guidance of $600 Mln to $620 Mln.

THOMSON REUTERS
·
Oct 30, 2025

Glaukos Corp. Advances in Glaucoma Treatment with New Clinical Trial

TIPRANKS
·
Oct 28, 2025

Stifel Nicolaus Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
Oct 27, 2025

Wells Fargo Upgrades Glaukos Corp to Overweight From Equalweight, Adjusts Price Target to $120 From $92

MT Newswires Live
·
Oct 27, 2025

Glaukos Raised to Overweight From Equal-Weight by Wells Fargo

Dow Jones
·
Oct 27, 2025

Glaukos Corp : Wells Fargo Raises to Overweight From Equal-Weight; Raises Target Price to $120 From $92

THOMSON REUTERS
·
Oct 27, 2025

Truist Financial Sticks to Their Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Oct 21, 2025

Analysts’ Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), Glaukos (GKOS)

TIPRANKS
·
Oct 21, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Arm Holdings, silver miners, Zions Bancorp

Reuters
·
Oct 21, 2025

Glaukos falls -10.3%

TIPRANKS
·
Oct 21, 2025

Glaukos Corp Shares up 1.7% After U.S. FDA Approves Co's New Eye Therapy

THOMSON REUTERS
·
Oct 20, 2025

Sector Update: Health Care Stocks Advance Pre-Bell Monday

MT Newswires Live
·
Oct 20, 2025

Glaukos Price Target Maintained With a $104.00/Share by BTIG

Dow Jones
·
Oct 20, 2025

US FDA approves Glaukos' new eye therapy

Reuters
·
Oct 20, 2025

Glaukos Wins FDA Approval for Epioxa Keratoconus Therapy

Reuters
·
Oct 20, 2025

Glaukos Announces FDA Approval of Epioxa™

THOMSON REUTERS
·
Oct 20, 2025